The Global Respiratory Assist Device Market Size accounted for USD 15,610 Million in 2021 and is anticipated to reach USD 44,132 Million by 2030 with a CAGR of 12.4% from 2022 to 2030.

Devices designed to assist patients who need assistance breathing, carbon dioxide removal, and therapy to prevent abdominal wall muscle atrophy due to lack of use are all examples of respiratory assist devices. The COVID-19 pandemic requires the use of respiratory assist devices, which are now more widely available thanks to EUAs that the FDA has issued. A noninvasive interface (such as a oral or nasal facial mask) and adjustable, varying levels (within a single respiratory cycle) of favorable air pressure are delivered by a respiratory assist device (RAD) without backup rate to support spontaneous respiratory efforts and increase the amount of inspired air that enters the lungs.

Market Dynamics

The growing prevalence of respiratory disorders is the primary factor boosting the global respiratory assist devices market. One of the most prevalent acute and chronic diseases in the world is respiratory disease. They happen in all societies, regardless of how advanced they are, and they affect people of all ages and social classes frequently. CRDs have an impact on the lungs' airways and other pulmonary structures. The most prevalent ones include pulmonary hypertension, asthma, occupational lung diseases, and chronic obstructive pulmonary disease (COPD). Air pollution, exposure to chemicals and dusts at work, and recurrent lower respiratory infections in children are additional risk factors in addition to tobacco smoke. According to the World Health Organization, over 262 million people suffer from asthma, a common disease among children.

The emergence of COVID-19 pandemic that affected millions of people caused breathing problems among many infected patients. The demand for respiratory assist devices increased a lot that it caused shortage within some months of the pandemic. The FDA has taken numerous steps to ensure that patients and healthcare professionals have timely access to high-quality medical devices so they can respond appropriately during the COVID-19 public health emergency. In order to expand the availability and capability of various therapeutic, diagnostic, and protective medical devices in high demand throughout the COVID-19 public health emergency, these actions involve issuing Emergency Use Authorizations (EUAs) and guidance documents.

Market Insights

The three categories of the global respiratory assist device market are product type, end-use, and region. The segmentation based on the product type includes cell respiratory consumables, inhalers, mechanical ventilators, nebulizers, pulse oximeters, oxygen concentrators, polysomnography devices, positive airway pressure devices, and spirometers. Ambulatory surgical centers, hospitals, clinics, long term care centers, and others are among the end-use segments included in the segmentation.

Global Respiratory Assist Device Market Geographical Competition

The North American, European, Latin American, Asian-Pacific, Middle Eastern, and African regions make up the five geographical segments of the global Respiratory Assist Device market. Due to better diagnosis, North America currently controls the market for respiratory care devices. The growth of the respiratory care devices market in the region will also be aided by the proper reimbursement policies during the forecast period. A substantial portion of growth in the respiratory care devices market is anticipated in Asia-Pacific as a result of the rising pollution levels in the developing country. Additionally, it is anticipated that the countries' initiatives will further fuel the region's market for respiratory care devices in the upcoming years.

Global Respiratory Assist Device Market Segment Analysis

Respiratory Assist Device Market By Product Type

·        Oxygen Concentrators

·        Inhalers

·        Nebulizers

·        Respiratory Consumables

·        Mechanical Ventilators

·        Positive Airway Pressure Devices

·        Polysomnography Devices

·        Pulse Oximeters

·        Spirometers

Respiratory Assist Device Market By End-Use

·        Ambulatory Surgical Centers

·        Clinics

·        Hospitals

·        Long Term Care Centers

·        Others

Respiratory Assist Device Market Leading Companies

This section of the study honors the market's top vendors Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, General Electric Healthcare Limited, Hamilton Medical AG, Inogen Inc., Koninklijke Philips N.V., Massimo Corporation, Medtronic plc., Teleflex Incorporated, Parexel International, ResMed Inc., and Smith’s Medical.

Respiratory Assist Device Market Regions

North America

·         U.S.

·         Canada

Europe

·         U.K.

·         Germany

·         France

·         Spain

·         Rest of Europe

Latin America

·         Brazil

·         Mexico

·         Rest of Latin America

Asia-Pacific

·         China

·         Japan

·         India

·         Australia

·         South Korea

·         Rest of Asia-Pacific

Middle East & Africa

·         GCC

·         South Africa

·         Rest of Middle East & Africa